Skip to main content
Top
Published in: Pediatric Nephrology 8/2006

01-08-2006 | Original Article

Topical hydrocortisone and physiotherapy for nonretractile physiologic phimosis in infants

Authors: Jung Won Lee, Su Jin Cho, Eun Ae Park, Seung Joo Lee

Published in: Pediatric Nephrology | Issue 8/2006

Login to get access

Abstract

The effect of hydrocortisone (HC), the steroid of lowest potency, and physiotherapy (PT) on non-retractile physiologic phimosis (PP) and the reduction of subsequent recurrent UTI was evaluated in male infants with UTI. Seventy-eight male infants with febrile UTI and nonretractile PP were prospectively randomized into HC (Plancol, n=39) and control (Vaseline, n=39) groups. Topical application of HC as a thin film around the preputial margin twice a day for four weeks with PT was instructed. The response rate in the HC group was 89.7% (35/39), which was significantly higher than the rate (20.5%; 8/39) in the control group (P<0.05). In the HC group, the response rate was much higher (96.1%) in the subgroup with PT than in the group without PT. Most of the response (88.5%) was observed within two weeks. During the following year, the recurrent rate of UTI was 7.1% (2/28) in the infants with retractile prepuces, which was significantly less than than the rate (29.6%; 8/27) in infants with nonretractile prepuces (P<0.05). In conclusion, topical HC and PT for 2–4 weeks proved to be a simple, safe and effective treatment for nonretractile PP in infants with UTI, and this procedure was beneficial in reducing recurrent UTI.
Literature
1.
go back to reference Oster J (1968) Further fate of the foreskin: Incidence of prepucial adhesions, phimosis and smegma among Danish school boys. Arch Dis Child 43:200–203CrossRef Oster J (1968) Further fate of the foreskin: Incidence of prepucial adhesions, phimosis and smegma among Danish school boys. Arch Dis Child 43:200–203CrossRef
2.
go back to reference Wiswell TE, Enzenauer RW, Holton ME, Comish JD, Hankins CT (1987) Declining frequency of circumcision: implication for changes in the absolute incidence and male to female sex ratio of urinary tract infection in early infancy. Pediatrics 79:338–342PubMed Wiswell TE, Enzenauer RW, Holton ME, Comish JD, Hankins CT (1987) Declining frequency of circumcision: implication for changes in the absolute incidence and male to female sex ratio of urinary tract infection in early infancy. Pediatrics 79:338–342PubMed
3.
go back to reference Hiraoka M, Tsukahara H, Ohshima Y, Mayumi M (2002) Meatus tightly covered by the prepuce is associated with urinary infection. Pediatr Int 44:658–662CrossRef Hiraoka M, Tsukahara H, Ohshima Y, Mayumi M (2002) Meatus tightly covered by the prepuce is associated with urinary infection. Pediatr Int 44:658–662CrossRef
4.
go back to reference Wiswell TE, Roscelli JD (1986) Corroborative evidence for the decreased incidence of urinary tract infections in circumcised male infants. Pediatrics 78:96–99PubMed Wiswell TE, Roscelli JD (1986) Corroborative evidence for the decreased incidence of urinary tract infections in circumcised male infants. Pediatrics 78:96–99PubMed
5.
go back to reference Herzog LW (1989) Urinary tract infection and circumcision: a case control study. Am J Dis Child 143:348–350CrossRef Herzog LW (1989) Urinary tract infection and circumcision: a case control study. Am J Dis Child 143:348–350CrossRef
6.
go back to reference Schon EJ, Colby CJ, Ray GT (2000) Newborn circumcision decrease incidence and costs of urinary tract infections during the first year of life. Pediatrics 105:789–793CrossRef Schon EJ, Colby CJ, Ray GT (2000) Newborn circumcision decrease incidence and costs of urinary tract infections during the first year of life. Pediatrics 105:789–793CrossRef
7.
go back to reference To T, Agha M, Dick PT, Feldman W (1998) Cohort study on circumcision of newborn boys and subsequent risk of urinary tract infection. Lancet 352:1813–1816CrossRef To T, Agha M, Dick PT, Feldman W (1998) Cohort study on circumcision of newborn boys and subsequent risk of urinary tract infection. Lancet 352:1813–1816CrossRef
8.
go back to reference Singh-Grewal D, Macdessi J, Craig J (2005) Circumcision for the prevention of urinary tract infection in boys: a systemic review of randomized trials and observational studies. Arch Dis Child 90:853–858CrossRef Singh-Grewal D, Macdessi J, Craig J (2005) Circumcision for the prevention of urinary tract infection in boys: a systemic review of randomized trials and observational studies. Arch Dis Child 90:853–858CrossRef
9.
go back to reference American Academy of Pediatrics (1999) Task force on circumcision. Circumcision policy statement. Pediatrics 103:686–693CrossRef American Academy of Pediatrics (1999) Task force on circumcision. Circumcision policy statement. Pediatrics 103:686–693CrossRef
10.
go back to reference Schon EJ, Wiswell TE, Moses S (2000) New policy on circumcision—causes for concern. Pediatrics 105:620–623CrossRef Schon EJ, Wiswell TE, Moses S (2000) New policy on circumcision—causes for concern. Pediatrics 105:620–623CrossRef
11.
go back to reference Jorgensen ET, Svensson A (1993) The treatment of phimosis in boys with a potent topical steroid (clobetasol propionate 0.05%) cream. Acta Derm Venereol 73:55–56PubMed Jorgensen ET, Svensson A (1993) The treatment of phimosis in boys with a potent topical steroid (clobetasol propionate 0.05%) cream. Acta Derm Venereol 73:55–56PubMed
12.
go back to reference Kikiros CS, Beasley SW, Woodward AA (1993) The response of phimosis to local steroid application. Pediatr Surg Int 8:329–332CrossRef Kikiros CS, Beasley SW, Woodward AA (1993) The response of phimosis to local steroid application. Pediatr Surg Int 8:329–332CrossRef
13.
go back to reference Wright JE (1994) The treatment of childhood phimosis with topical steroid. Aust NZJ Surg 64:327–328CrossRef Wright JE (1994) The treatment of childhood phimosis with topical steroid. Aust NZJ Surg 64:327–328CrossRef
14.
go back to reference Lindhagen T (1996) Topical clobetasol propionate compared with placebo in the treatment of unretractable foreskin. Eur J Surg 162:969–972PubMed Lindhagen T (1996) Topical clobetasol propionate compared with placebo in the treatment of unretractable foreskin. Eur J Surg 162:969–972PubMed
15.
go back to reference Golubovic Z, Milanovic D, Vukadinovic V, Rakic I, Perovic S (1996) The conservative treatment of phimosis in boys. Br J Urol 78:786–788CrossRef Golubovic Z, Milanovic D, Vukadinovic V, Rakic I, Perovic S (1996) The conservative treatment of phimosis in boys. Br J Urol 78:786–788CrossRef
16.
go back to reference Monsour MA, Rabinovitch HH, Dean GE (1999) Medical management of phimosis in children: our experience with topical steroids. J Urol 162:1162–1164CrossRef Monsour MA, Rabinovitch HH, Dean GE (1999) Medical management of phimosis in children: our experience with topical steroids. J Urol 162:1162–1164CrossRef
17.
go back to reference Chu CC, Chen KC, Diau GY (1999) Topical steroid treatment of phimosis in boys. J Urol 162:861–863CrossRef Chu CC, Chen KC, Diau GY (1999) Topical steroid treatment of phimosis in boys. J Urol 162:861–863CrossRef
18.
go back to reference Lund L, Wai KH, Mui LM, Yeung CK (2000) Effect of topical steroid on non-retractile prepubertal foreskin by a prospective, randomized, double-blind study. Scand J Urol Nephrol 34:267–269CrossRef Lund L, Wai KH, Mui LM, Yeung CK (2000) Effect of topical steroid on non-retractile prepubertal foreskin by a prospective, randomized, double-blind study. Scand J Urol Nephrol 34:267–269CrossRef
19.
go back to reference Orsola A, Caffaratti J, Garat JM (2000) Conservative treatment of phimosis in children using a topical steroid. Urology 56:307–310CrossRef Orsola A, Caffaratti J, Garat JM (2000) Conservative treatment of phimosis in children using a topical steroid. Urology 56:307–310CrossRef
20.
go back to reference Webster TM, Leonard MP (2002) Topical steroid therapy for phimosis. Can J Urol 9:1492–1495PubMed Webster TM, Leonard MP (2002) Topical steroid therapy for phimosis. Can J Urol 9:1492–1495PubMed
21.
go back to reference Ashfield JE, Nickel KR, Siemens DR, McNeily AE (2003) Treatment of phimosis with topical steroid in 194 children. J Urol 169:1106–1108CrossRef Ashfield JE, Nickel KR, Siemens DR, McNeily AE (2003) Treatment of phimosis with topical steroid in 194 children. J Urol 169:1106–1108CrossRef
22.
go back to reference Lund L, Wai KH, Mui LM, Yeung CK (2005) An 18-month follow-up study after randomized treatment of phimosis in boys with topical steroid versus placebo. Scan J Urol Nephrol 39:78–81CrossRef Lund L, Wai KH, Mui LM, Yeung CK (2005) An 18-month follow-up study after randomized treatment of phimosis in boys with topical steroid versus placebo. Scan J Urol Nephrol 39:78–81CrossRef
23.
go back to reference Yang SS, Tsai YC, Wu CC, Liu SP, Wang CC (2005) Highly potent and moderately potent topical steroids are effective in treating phimosis: a prospective randomized study. J Urol 173:1361–1363CrossRef Yang SS, Tsai YC, Wu CC, Liu SP, Wang CC (2005) Highly potent and moderately potent topical steroids are effective in treating phimosis: a prospective randomized study. J Urol 173:1361–1363CrossRef
24.
go back to reference Elmore JM, Baker LA, Snodgrass WT (2002) Topical steroid therapy as an alternative to circumcision for phimosis in boys younger than 3 years. J Urol 168:1746–1747CrossRef Elmore JM, Baker LA, Snodgrass WT (2002) Topical steroid therapy as an alternative to circumcision for phimosis in boys younger than 3 years. J Urol 168:1746–1747CrossRef
25.
go back to reference Hammarstrom S, Hamburg M, Duell EA, Stawiski MA, Anderson TF, Vorhees JJ (1977) Glucocorticoid in inflammatory skin disease reduces arachdonic and hydroxyeicosatetranoic acids. Science 197:994–996CrossRef Hammarstrom S, Hamburg M, Duell EA, Stawiski MA, Anderson TF, Vorhees JJ (1977) Glucocorticoid in inflammatory skin disease reduces arachdonic and hydroxyeicosatetranoic acids. Science 197:994–996CrossRef
26.
go back to reference Lewis GP, Piper PJ (1975) Inhibition of release of prostaglandin as an explanation of some of the actions of anti-inflammatory corticosteroids. Nature 254:308–311CrossRef Lewis GP, Piper PJ (1975) Inhibition of release of prostaglandin as an explanation of some of the actions of anti-inflammatory corticosteroids. Nature 254:308–311CrossRef
27.
go back to reference Gavan N, Maibach H (1997) Effect of topical corticosteroids on the activity of superoxide dismutase in human skin in vitro. Skin Pharmacol 10:309–313CrossRef Gavan N, Maibach H (1997) Effect of topical corticosteroids on the activity of superoxide dismutase in human skin in vitro. Skin Pharmacol 10:309–313CrossRef
28.
go back to reference Van Howe RS (1998) Cost effective treatment of phimosis. Pediatrics 102:1–4CrossRef Van Howe RS (1998) Cost effective treatment of phimosis. Pediatrics 102:1–4CrossRef
29.
go back to reference Berdeu D, Sauze L, Ha-Vinh P, Blum-Boisgard C (2001) Cost effectiveness analysis of treatments for phimosis: a comparison of surgical and medical approachs and their economic effects. Br J Urol 87:239–241CrossRef Berdeu D, Sauze L, Ha-Vinh P, Blum-Boisgard C (2001) Cost effectiveness analysis of treatments for phimosis: a comparison of surgical and medical approachs and their economic effects. Br J Urol 87:239–241CrossRef
30.
go back to reference Wiswell TE, Geschike DW (1989) Risks from circumcision during the first months of life compared with those for uncircumcised boys. Pediatrics 83:1011–1015PubMed Wiswell TE, Geschike DW (1989) Risks from circumcision during the first months of life compared with those for uncircumcised boys. Pediatrics 83:1011–1015PubMed
31.
go back to reference Cooper GG, Thomson GJ, Raine PA (1983) Therapeutic retraction of the foreskin in childhood. Br Med J (Clin Res Ed) 286:186–187CrossRef Cooper GG, Thomson GJ, Raine PA (1983) Therapeutic retraction of the foreskin in childhood. Br Med J (Clin Res Ed) 286:186–187CrossRef
Metadata
Title
Topical hydrocortisone and physiotherapy for nonretractile physiologic phimosis in infants
Authors
Jung Won Lee
Su Jin Cho
Eun Ae Park
Seung Joo Lee
Publication date
01-08-2006
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 8/2006
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0104-8

Other articles of this Issue 8/2006

Pediatric Nephrology 8/2006 Go to the issue

Letter to the Editors

Cysteamine dose regimen